Cluster-Randomized Trial of Air Filtration and Ventilation to Reduce Covid19 Spread in Homes
NCT05777720 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 214
Last updated 2026-02-19
Summary
Investigators are evaluating whether an intervention consisting of box-fans with MERV 16 filters ("filtration fans") and recommendations for improving ventilation in the home can reduce secondary spread of Covid19 from an index case to susceptible contacts within the home.
Conditions
- Covid19
Interventions
- DEVICE
-
Filtration Fan
Investigators are using box fans with attached MERV16 filters, a design that has been tested and published in the scientific literature.
- BEHAVIORAL
-
Safe-home pamphlet
The pamphlet has information on how the filtration fans work through visual images; and images of ventilation improvements in the home through opening windows.
- BEHAVIORAL
-
Mid-week phone call
On day 3-4 of the study, the study coordinator assigned to the house will call and check in regarding the filtration fan usage and remind families about the importance of filtration and ventilation.
Sponsors & Collaborators
-
National Institute of Allergy and Infectious Diseases (NIAID)
collaborator NIH - lead OTHER
Principal Investigators
-
Yvonne Maldonado, MD · Stanford University
-
Abraar Karan, MD · Stanford University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-01-30
- Primary Completion
- 2025-12-30
- Completion
- 2025-12-30
Countries
- United States
Study Locations
More Related Trials
-
Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection
NCT05897541 ·Status: COMPLETED ·Phase: PHASE3
-
Face Masks for Preventing Influenza Transmission
NCT00774774 ·Status: COMPLETED ·Phase: PHASE4
-
COVID-19 Convalescent Plasma for Mechanically Ventilated Population
NCT04388527 ·Status: COMPLETED ·Phase: PHASE1
-
Home Usability Study of the SARS-CoV-2 (COVID-19) Test
NCT04395391 ·Status: COMPLETED
-
PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)
NCT05780541 ·Status: TERMINATED ·Phase: PHASE3
-
Administration of Anti-SARS-CoV-2 Convalescent Plasma in Hospitalized, Non-ICU Patients With COVID-19
NCT04467151 ·Status: WITHDRAWN ·Phase: PHASE2
-
Phase 3 Open-Label Controlled Trial of Convalescent Plasma in Early COVID-19 Infection
NCT06084351 ·Status: WITHDRAWN ·Phase: PHASE3
-
Exploratory Study of Aerosol Inhalation of FB2001 for Post-exposure Prophylaxis of COVID-19 Close Contacts
NCT05415241 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Plasma Therapy of COVID-19 in Severely Ill Patients
NCT04359810 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-19 Algorithm Treatment at Home
NCT05413642 ·Status: WITHDRAWN ·Phase: PHASE3
-
PREvent Viral Exposure and Transmission Study: a COVID-19 (SARS-CoV-2) PEP Study (PREVENT)
NCT04842331 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
COVFIS-HOME: COVID-19 Pilot Study of Fisetin to Alleviate Dysfunction and Decrease Complications
NCT04771611 ·Status: COMPLETED ·Phase: PHASE2
-
Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)
NCT04554992 ·Status: COMPLETED ·Phase: PHASE1
-
Phase 3 Efficacy and Safety Study of Favipiravir for Treatment of Uncomplicated Influenza in Adults - T705US316
NCT02026349 ·Status: COMPLETED ·Phase: PHASE3
-
Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)
NCT04397692 ·Status: TERMINATED ·Phase: NA
-
Pharmacokinetics, Pharmacodynamics and Safety Evaluation of SAR279356 in Intensive Care Unit Mechanically Ventilated Patients
NCT01389700 ·Status: TERMINATED ·Phase: PHASE2
-
Convalescent Plasma in the Treatment of COVID 19
NCT04343261 ·Status: COMPLETED ·Phase: PHASE2
-
Community Collaboration to Combat COVID-19 (C-FORWARD)
NCT04673292 ·Status: COMPLETED ·Phase: NA
-
Evaluate Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Covid-19 in China
NCT05682599 ·Status: UNKNOWN ·Phase: PHASE2
-
Convalescent Plasma for Treatment of COVID-19 Patients With Pneumonia
NCT04374565 ·Status: COMPLETED ·Phase: PHASE2
-
COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes
NCT04537299 ·Status: TERMINATED ·Phase: PHASE2
-
Convalescent Plasma in the Early Treatment of High-Risk Patients With SARS-CoV-2 (COVID-19) Infection
NCT04513158 ·Status: TERMINATED ·Phase: PHASE2
-
Efficacy of Convalescent Plasma Therapy in Patients With COVID-19
NCT04425915 ·Status: COMPLETED ·Phase: PHASE3
-
Convalescent Plasma for the Treatment of Severe SARS-CoV-2 (COVID-19)
NCT04391101 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of Convalescent Plasma to Treat COVID-19 Patients, a Nested Trial in the CORIMUNO-19 Cohort
NCT04345991 ·Status: COMPLETED ·Phase: PHASE2